Therefore, stable MAPK11 knockdown ccRCC cell lines were prepared for the purpose of determining whether P‐MAPK11 could regulate the RUNX2 protein in ccRCC cells in our study. This evidence concerns the gene MAPK11 and nonpapillary renal cell carcinoma.